Research Square (Research Square),
Journal Year:
2022,
Volume and Issue:
unknown
Published: March 7, 2022
Abstract
Background
:
A
vaccine
against
COVID-19
is
a
vital
tool
in
managing
the
current
pandemic.
It
becoming
evident
that
an
effective
would
be
required
to
control
COVID-19.
Effective
use
of
vaccines
important
reducing
pandemic
and
paving
way
for
acceptable
exit
strategy.
Therefore,
review
aimed
determine
global
acceptance
rate
necessary
better
management
Materials
Methods
This
was
conducted
under
Preferred
Reporting
Items
Systematic
Reviews
Meta-Analysis
protocols
considered
studies
on
/
or
hesitancy
around
world,
written
English
language.
Articles
were
searched
using
electronic
databases
including
PubMed
MEDLINE,
Scopus
/Science
Direct,
Web
Science,
Embase,
CINAHL,
Google
Scholars.
The
quality
study
assessed
Joanna
Briggs
Institute
Critical
Assessment
prevalence
relevance
each
included
article
study.
Results
pooled
found
61.1%
[95%
CI:
53.8,
67.9%
with
p-value
<0.001].
Based
subgroup
analysis
by
publication
year,
reported
published
2020
2021
74.2
%
66.5,
80.7%]
47.9%
37.8,
58.2%],
respectively,
resulting
overall
63.7%
56.8,
69.5%].
survey
period,
from
March
May
[80.0%
(95%
68.8,
87.9%)],
June
August
[58.6%
38.0,
76.6%)]
September
December
[46.3%
37.4,
55.8%)].
Conclusions
decreasing
level
vaccine.
finding
indicated
even
if
developed,
issue
accepting
taking
developed
may
difficult.
Journal of Multidisciplinary Healthcare,
Journal Year:
2022,
Volume and Issue:
Volume 15, P. 21 - 45
Published: Jan. 1, 2022
Abstract:
The
delay
or
refusal
of
vaccination,
which
defines
vaccine
hesitancy,
is
a
major
challenge
to
successful
control
COVID-19
epidemic.
huge
number
publications
addressing
hesitancy
necessitates
periodic
review
provide
concise
summary
acceptance
rates
worldwide.
In
the
current
narrative
review,
data
on
were
retrieved
from
surveys
in
114
countries/territories.
East
and
Southern
Africa
(n
=
9),
highest
rate
was
reported
Ethiopia
(92%),
while
lowest
Zimbabwe
(50%).
West/Central
13),
Niger
(93%),
Cameroon
(15%).
Asia
Pacific
16),
Nepal
Vietnam
(97%),
Hong
Kong
(42%).
Eastern
Europe/Central
7),
Montenegro
(69%)
Kazakhstan
(64%),
Russia
(30%).
Latin
America
Caribbean
20),
Mexico
(88%),
Haiti
(43%).
Middle
East/North
(MENA,
n
22),
Tunisia
Iraq
(13%).
Western/Central
Europe
North
27),
Canada
(91%)
Norway
(89%),
Cyprus
Portugal
(35%).
≥
60%
seen
72/114
countries/territories,
compared
42
countries/territories
with
between
13%
59%.
phenomenon
appeared
more
pronounced
MENA,
Central
Asia,
Africa.
More
studies
are
recommended
Africa,
address
intentions
general
public
get
vaccination.
Keywords:
SARS-CoV-2,
hesitance,
resistance,
rejection,
willingness
vaccinate,
intention
vaccinate
Frontiers in Medicine,
Journal Year:
2022,
Volume and Issue:
8
Published: Jan. 27, 2022
Introduction
Vaccination
is
an
essential
intervention
to
curb
the
coronavirus
disease
2019
(COVID-19)
pandemic.
This
review
aimed
estimate
pooled
proportion
of
COVID-19
vaccine
acceptance
worldwide.
Methods
A
systematic
search
MEDLINE
(PubMed)
database
using
“COVID-19,”
“vaccine”
and
“acceptance”
obtain
original
research
articles
published
between
2020
July
2021.
Only
studies
with
full
text
that
were
in
English
included.
The
Joanna
Briggs
Institute
meta-analysis
was
used
assess
data
quality.
performed
generic
inverse
variance
a
random-effects
model
Review
Manager
software.
Results
total
172
across
50
countries
worldwide
Subgroup
analyses
regard
acceptance,
regions,
population,
gender,
effectiveness,
survey
time.
61%
(95%
CI:
59,
64).
It
higher
Southeast
Asia,
among
healthcare
workers,
males,
for
vaccines
95%
during
first
survey.
Conclusion
needs
be
increased
achieve
herd
immunity
protect
population
from
disease.
crucial
enhance
public
awareness
vaccination
improve
access
vaccines.
Systematic
Registration
PROSPERO
2021,
identifier
CRD42021268645.
BMC Public Health,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: March 6, 2023
Abstract
Background
The
COVID-19
pandemic
has
exacerbated
health
disparities
in
vulnerable
groups
(e.g.,
increased
infection,
hospitalization,
and
mortality
rates
people
with
lower
income,
education,
or
ethnic
minorities).
Communication
inequalities
can
act
as
mediating
factors
this
relationship.
Understanding
link
is
vital
to
prevent
communication
public
crises.
This
study
aims
map
summarize
the
current
literature
on
linked
(CIHD)
during
identify
research
gaps.
Methods
A
scoping
review
of
quantitative
qualitative
evidence
was
conducted.
search
followed
guidelines
PRISMA
extension
for
reviews
performed
PubMed
PsycInfo.
Findings
were
summarized
using
a
conceptual
framework
based
Structural
Influence
Model
by
Viswanath
et
al.
Results
yielded
92
studies,
mainly
assessing
low
education
social
determinant
knowledge
an
indicator
inequalities.
CIHD
identified
45
studies.
association
insufficient
inadequate
preventive
behavior
most
frequently
observed.
Other
studies
only
found
part
link:
(
n
=
25)
5).
In
17
neither
nor
found.
Conclusions
supports
findings
past
Public
institutions
should
specifically
target
their
reduce
More
about
needed
migrant
status,
financial
hardship,
not
speaking
language
country
residence,
sexual
minorities,
living
deprived
neighborhoods.
Future
also
assess
input
derive
specific
strategies
overcome
Human Vaccines & Immunotherapeutics,
Journal Year:
2021,
Volume and Issue:
17(12), P. 4873 - 4888
Published: Dec. 14, 2021
A
cross-sectional
field
survey
was
conducted
from
November
2020
to
January
2021
among
7259
participants
investigate
the
public
perception,
willingness,
and
information
sources
for
COVID-19
vaccination,
with
focus
on
elderly
non-communicable
chronic
disease
(NCD)
population.
Multiple
logistic
regressions
were
performed
identify
associated
factors
of
vaccination
willingness.
The
willingness
rate
accept
future
vaccine
(79.08%)
lower
than
that
adults
aged
18-59
(84.75%).
multiple
analysis
didn't
significant
relationship
between
NCD
status
intention.
main
reasons
hesitancy
by
were:
concern
safety,
low
infection
risk,
waiting
seeing
others
getting
vaccinated,
effectiveness
price.
Their
relative
importance
differed
elderly,
or
without
NCD.
Perception
importance,
confidence,
trust
in
health
workers
predictors
intention
both
age
groups.
who
perceived
high
risk
had
governments
more
likely
vaccine.
Compared
18-59,
used
fewer
trusted
traditional
media
family,
relatives,
friends
recommendations.
To
promote
uptake,
campaigns
require
comprehensive
interventions
improve
attitude,
accessibility
affordability,
tailor
strategies
address
specific
concerns
different
population
groups
via
their
sources,
especially
elderly.
Journal of Infection and Public Health,
Journal Year:
2021,
Volume and Issue:
14(10), P. 1489 - 1496
Published: Aug. 13, 2021
People
with
chronic
conditions
such
as
cancer,
kidney
disease,
lung
diabetes,
dementia,
obesity,
and
heart
are
at
elevated
risk
of
developing
severe
complications,
thus
greater
death
due
to
COVID-19.
The
COVID-19
vaccine
is
an
effective
measure
manage
the
pandemic
it
prevents
illness
death.
Nevertheless,
many
people
hesitant
receive
fear
its
side
effects.
aim
this
study
was
identify
protective
factors
accepting
vaccination
among
Saudi
Arabian
diseases.
This
extracted
data
from
online
cross-sectional
self-reported
questionnaire
conducted
on
acceptability
a
in
Arabia
December
2020.
included
sample
521
adults
who
that
they
had
Multivariable
regression
analyses
were
employed
associated
Arabia.
estimates
adjusted
for
confounding
variables,
including
socio-demographic
factors.
Among
sampled
participants
diseases,
approximately
52%
indicated
willing
accept
vaccine.
Participants
higher
willingness
if
received
seasonal
influenza
past
[odds
ratio
(OR):
2.179;
95%
confidence
interval
(CI):
1.222–3.888],
reported
high
or
very
levels
concern
about
contracting
(OR:
2.426;
CI:
1.209–4.867),
believed
mandatory
84.848;
37.651–191.207).
lower
be
vaccinated
history
refusal
0.211;
0.088–0.504).
factors,
being
male
2.153;
1.007–4.603),
having
postgraduate
degree
2.408;
0.985–5.886),
unemployed
2.780;
0.876–8.827)
increased
receiving
findings
demonstrate
low.
Therefore,
further
policy
measures
required
COVID-19–related
infections
toll.
Frontiers in Public Health,
Journal Year:
2022,
Volume and Issue:
10
Published: April 29, 2022
Background
The
hesitancy
in
taking
the
COVID-19
vaccine
is
a
global
challenge.
need
to
identify
predictors
of
reluctance
critical.
Our
objectives
were
evaluate
sociodemographic,
psychological,
and
behavioral
factors,
as
well
attitudes
beliefs
that
influence
vaccination
general
population
Italy.
Methods
A
total
2,015
people
assessed
two
waves
(March,
April
May,
2021).
Participants
divided
into
three
groups:
(1)
individuals
who
accepted
(“accepters”);
(2)
refused
(“rejecters”);
(3)
uncertain
about
their
toward
(“fence
sitters”).
Group
comparisons
performed
using
ANOVA,
Kruskal-Wallis
test
chi-square
tests.
strength
association
between
groups
participants'
characteristics
was
analyzed
series
multinomial
logistic
regression
models
with
bootstrap
internal
validation
(one
for
each
factor).
Results
“fence
sitters”
group,
when
compared
others,
included
younger
age,
lower
educational
level,
worsening
economic
situation
previous
3
months.
After
controlling
sociodemographic
following
features
emerged
main
risk
factors
being
(compared
“accepters”):
reporting
levels
protective
behaviors,
trust
institutions
informational
sources,
frequency
use
agreement
restrictions
higher
conspirative
mentality.
Higher
perceived
risk,
behaviors
associated
likelihood
becoming
rather
than
“rejecters.”
Conclusions
profile
revealed
by
this
study
intriguing
should
be
focus
public
programmes
aimed
at
improving
adherence
campaign.
Human Vaccines & Immunotherapeutics,
Journal Year:
2021,
Volume and Issue:
17(12), P. 4982 - 4992
Published: Oct. 6, 2021
The
purpose
of
this
study
was
to
identify
the
main
barriers
vaccine
acceptance
among
medical
students
in
Kazakhstan
and
develop
COVID-19
Vaccine
Hesitancy
Scale
(COV-VHS).
A
cross-sectional
carried
out
at
Astana
Medical
University
(N
=
888,
Kazakhstan)
March
2021.
Only
2%
participants
were
currently
vaccinated,
22.4%
showed
potential
for
acceptance.
following
most
important
acceptance:
concern
about
possible
side
effects
vaccination
(73%),
absence
sufficient
evidence
on
effectiveness
safety
(57%)
quality
(42%),
belief
that
immune
system
will
cope
with
even
without
(38%),
lack
trust
against
(33%).
Moreover,
identified
factors
associated
contextual
influences
(e.g.,
communication
media
environment,
socio-demographic
factors,
policies,
perception
pharmaceutical
industry),
individual
group
personal
experience
vaccination,
attitudes
health
prevention,
providers,
perceived
risk),
specific
issues
vaccine/vaccination
choice
can
reduce
hesitancy
by
30%).
developed
12-item
6-factor
model
COV-VHS
good
validity
reliability.
In
conclusion,
there
a
low-level
Kazakhstan.
Thus,
an
effective
education
policy
are
needed
combat
pandemic.
Frontiers in Public Health,
Journal Year:
2022,
Volume and Issue:
10
Published: Dec. 8, 2022
A
vaccine
against
COVID-19
is
a
vital
tool
in
managing
the
current
pandemic.
It
becoming
evident
that
an
effective
would
be
required
to
control
COVID-19.
Effective
use
of
vaccines
very
important
controlling
pandemics
and
paving
way
for
acceptable
exit
strategy.
Therefore,
this
systematic
review
meta-analysis
aims
determine
global
acceptance
rate
necessary
better
management
Human Vaccines & Immunotherapeutics,
Journal Year:
2021,
Volume and Issue:
17(11), P. 4048 - 4056
Published: Aug. 6, 2021
To
evaluate
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
vaccine
acceptance
among
patients
with
rheumatic
diseases
(RMD).All
rheumatology
attending
a
large
suburban
health
network
were
invited
to
participate
in
an
anonymized
online
survey.
The
primary
outcome
of
interest
was
SARS-COV-2
acceptance.The
mean
(SD)
age
respondents
(n
=
641)
52.7
(15.1)
years
and
74.4%
474)
female.
Sixty-five
percent
willing
have
vaccine,
while
34.4%
vaccine-hesitant
(unwilling
or
undecided).
On
multivariate
analysis,
associated
smoking
(OR:
2.25
[95%
CI:
1.22-4.15;
p
.009]),
history
malignancy
2.51
1.19-5.26;
.015]),
influenza
pneumococcal
vaccination
the
preceding
year
2.69
1.78-4.05;
<
.001])
number
COVID-Safe
measures
practiced
1.54
1.05-2.26;
.027]).
Vaccine
correlated
positive
beliefs
regarding
efficacy
(r
0.40;
.001)
safety
0.36;
.001).
negatively
concerns
side-effects
-0.30;
vaccine-associated
RMD
flare
-0.21;
In
respondents,
39.2%
more
likely
accept
if
given
choice
which
they
receive
54.5%
their
rheumatologist
recommended
it.
Twenty-seven
on
immunomodulators
withhold
medications
42.1%
advised
by
rheumatologist.SARS-COV-2
hesitancy
is
prevalent
amongst
safety,
efficacy,
side
effects
flare.
Clinician
recommendation,
communications
targeting
patient
could
facilitate
acceptance.Significance
Innovations
patientsVaccine
effectsVaccine
clinician
recommendation
potential
improve
who
are
hesitant.